|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/44 | |||
| A61K 31/4748 | |||
| A61P 25/28 |
| (11) | Number of the document | 2931315 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13831902.5 |
| Date of filing the European patent application | 2013-12-09 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/060744 |
| Date | 2013-12-09 |
| (87) | Number | WO 2014/091388 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261735720 P | 2012-12-11 | US |
| (72) |
Feuerbach, Dominik, CH
Gomez-Mancilla, Baltazar, CH
HE, Yunsheng, US
Johns, Donald, US
Lopez-Lopez, Cristina, CH
MCAllister, Kevin Hall, CH
Pezous, Nicole, CH
Sandford, Lisa, CH
Weiss, Markus, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATOR TREATMENT |
| BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATOR TREATMENT |